Suppr超能文献

基于自组装肽的新型止血剂在鼻内镜手术中的应用:病例系列

A novel haemostatic agent based on self-assembling peptides in the setting of nasal endoscopic surgery, a case series.

作者信息

Lee M F, Ma Z, Ananda A

机构信息

Royal Prince Alfred Hospital, 50 Missenden Rd, Camperdown, NSW, 2050, Australia.

出版信息

Int J Surg Case Rep. 2017 Nov 20;41:461-464. doi: 10.1016/j.ijscr.2017.11.024. eCollection 2017.

Abstract

INTRODUCTION

Recently, a novel purely synthetic topical haemostatic agent (PuraStat) has been proposed in surgery based on the self-assembling tendency of some repeating peptide sequences. This transparent, ready to use hydrogel appears suitable for use in FEES with low rates of post-operative re-bleeding and adhesion formation.A first series of 60 patients experiencing endonasal powered turbinoplasty across various hospitals in Sydney using PuraStat was observed for postoperative re-bleeding and adhesion formation.

DISCUSSION

In all 60 patients, no post-operative re-bleeding was observed, while healing went well in absence of adhesion formation. Effective haemostasis with PuraStat is well documented in other surgical fields, but its use in FEES and adhesion prevention is relatively novel.

CONCLUSION

Synthetic self-assembling peptides appear to be indicated in this area. Further studies are needed to confirm their potential for adhesion prevention.

摘要

引言

最近,基于一些重复肽序列的自组装倾向,一种新型的纯合成局部止血剂(PuraStat)已被应用于外科手术中。这种透明、即用型水凝胶似乎适用于功能性鼻内镜鼻窦手术(FEES),术后再出血率和粘连形成率较低。观察了悉尼各医院使用PuraStat进行鼻内动力鼻甲成形术的首批60例患者的术后再出血和粘连形成情况。

讨论

在所有60例患者中,均未观察到术后再出血,且愈合良好,未形成粘连。PuraStat在其他外科领域的有效止血已有充分记录,但其在功能性鼻内镜鼻窦手术和预防粘连方面的应用相对较新。

结论

合成自组装肽似乎适用于该领域。需要进一步研究以证实其预防粘连的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e751/5709301/9af7e3e4c112/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验